capecitabine has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (36.36) | 29.6817 |
2010's | 6 (54.55) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
Authors | Studies |
---|---|
Gutiérrez-Collar, C; Mitsunaga, K; Montero-Menárguez, J; Peralto, JLR; Puerta-Peña, M; Velasco-Tamariz, V | 1 |
Marsch, AF; Shakhbazova, A | 1 |
Chou, CY; Hsieh, CI; Ko, JH; Wang, KH | 1 |
Chiche, L; Dicostanzo, MP; Fongue, J; Harlé, JR; Lardet, D; Meunier, B; Richard, MA; Rouby, F; Terrier, JP | 1 |
Jiang, N; Li, Z; Xu, Y | 1 |
Kim, BS; Kim, GW; Kim, HS; Kim, JM; Kim, MB; Kim, WI; Ko, HC; Mun, JH; Song, M | 1 |
Aberer, E; Gerger, A; Kränke, B; Salmhofer, W; Weger, W | 1 |
Elenitsas, R; Fernandes, NF; Kist, JM; Rosenbach, M | 1 |
Casado-Jiménez, M; Feito-Rodriguez, M; Feltes, RA; Floristan, U; Ramírez-Marín, P; Sendagorta, E; Vidaurrázaga, C | 1 |
Guillen, C; Kindem, S; Llombart, B; Requena, C; Ruiz, A; San Martin, O; Traves, V | 1 |
Coras, B; Hafner, C; Landthaler, M; Reichle, A; Vogt, T | 1 |
1 review(s) available for capecitabine and Lupus Erythematosus, Cutaneous, Subacute
Article | Year |
---|---|
Systemic 5-fluorouracil induced lupus erythematosus: a review of the literature.
Topics: Age Distribution; Aged; Antimetabolites, Antineoplastic; Capecitabine; Female; Fluorouracil; Humans; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Male; Middle Aged; Sex Distribution; Tegafur | 2019 |
10 other study(ies) available for capecitabine and Lupus Erythematosus, Cutaneous, Subacute
Article | Year |
---|---|
Subacute cutaneous lupus erythematosus induced by Capecitabine: Confocal microscopy and dermoscopy findings.
Topics: Antimetabolites, Antineoplastic; Capecitabine; Dermoscopy; Humans; Lupus Erythematosus, Cutaneous; Microscopy, Confocal | 2022 |
Capecitabine-induced subacute cutaneous lupus erythematosus: report of a case with positive rechallenge test.
Topics: Aged; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Female; Fluorouracil; Humans; Lupus Erythematosus, Cutaneous; Stomach Neoplasms | 2013 |
[Capecitabine-induced subacute cutaneous lupus: a case report].
Topics: Adverse Drug Reaction Reporting Systems; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Diagnosis, Differential; Female; Fluorouracil; France; Humans; Lupus Erythematosus, Cutaneous; Middle Aged | 2014 |
The concurrence of subacute cutaneous lupus erythematosus and hand-foot syndrome in a patient undergoing capecitabine chemotherapy.
Topics: Aged; Antimetabolites, Antineoplastic; Capecitabine; Female; Hand-Foot Syndrome; Humans; Lupus Erythematosus, Cutaneous | 2016 |
Subacute cutaneous lupus erythematosus induced by capecitabine: 5-FU was innocent.
Topics: Aged; Antineoplastic Agents; Capecitabine; Colonic Neoplasms; Female; Fluorouracil; Humans; Lupus Erythematosus, Cutaneous | 2016 |
Occurrence of subacute cutaneous lupus erythematosus after treatment with fluorouracil and capecitabine.
Topics: Acute Disease; Administration, Oral; Aged; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Fatal Outcome; Female; Fluorouracil; Humans; Lupus Erythematosus, Cutaneous; Severity of Illness Index; Steroids; Stomach Neoplasms | 2008 |
Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy.
Topics: Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Female; Fluorouracil; Humans; Lupus Erythematosus, Cutaneous; Middle Aged | 2009 |
Subacute cutaneous lupus erythematosus induced by capecitabine.
Topics: Aged; Antimetabolites, Antineoplastic; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Drug Eruptions; Facial Dermatoses; Female; Fluorouracil; Humans; Lupus Erythematosus, Cutaneous | 2009 |
Subacute cutaneous lupus erythematosus after treatment with capecitabine.
Topics: Aged; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Deoxycytidine; Female; Fluorouracil; Humans; Lupus Erythematosus, Cutaneous | 2013 |
Antiangiogenic therapy in metastatic prostate carcinoma complicated by cutaneous lupus erythematodes.
Topics: Angiogenesis Inhibitors; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Capecitabine; Cyclophosphamide; Deoxycytidine; Drug Administration Schedule; Fluorouracil; Humans; Liver Neoplasms; Lupus Erythematosus, Cutaneous; Male; Middle Aged; Paraneoplastic Syndromes; Pioglitazone; Prostatic Neoplasms; Thiazolidinediones | 2006 |